JLK, Inc. (KOSDAQ:322510)
7,230.00
-250.00 (-3.34%)
At close: Jan 30, 2026
JLK, Inc. Market Cap
JLK, Inc. has a market cap or net worth of 182.11 billion as of January 30, 2026. Its market cap has decreased by -17.09% in one year.
Market Cap
182.11B
Enterprise Value
158.80B
Revenue
3.26B
Ranking
n/a
PE Ratio
n/a
Stock Price
7,230.00
Market Cap Chart
Since December 11, 2019, JLK, Inc.'s market cap has increased from 134.05B to 182.11B, an increase of 35.85%. That is a compound annual growth rate of 5.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 188.41B | 34.53% |
| Dec 30, 2025 | 140.05B | -31.62% |
| Dec 30, 2024 | 204.81B | -41.08% |
| Dec 28, 2023 | 347.59B | 635.63% |
| Dec 29, 2022 | 47.25B | -58.24% |
| Dec 30, 2021 | 113.15B | -24.49% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kolon | 776.69B |
| OCI Company | 637.42B |
| Samyang Holdings | 423.91B |
| KG Chemical | 393.99B |
| KPX Holdings | 298.14B |
| HS HYOSUNG | 240.53B |
| Aprogen Medicines | 239.43B |
| Woongjin | 191.96B |